Learning curve of lung dose optimization in intensity-modulated radiotherapy for locally advanced non-small cell lung cancer

被引:2
作者
Igari, Mitsunobu [1 ]
Abe, Takanori [1 ,2 ]
Iino, Misaki [1 ]
Saito, Satoshi [1 ]
Aoshika, Tomomi [1 ]
Ryuno, Yasuhiro [1 ]
Ohta, Tomohiro [1 ]
Hirai, Ryuta [1 ]
Kumazaki, Yu [1 ]
Noda, Shin-ei [1 ]
Kato, Shingo [1 ]
机构
[1] Saitama Med Univ, Int Med Ctr, Dept Radiat Oncol, Saitama, Japan
[2] Saitama Med Univ, Int Med Ctr, Dept Radiat Oncol, Saitama 3501298, Japan
关键词
intensity-modulated radiotherapy; learning curve; lung cancer; lung dose; optimization; RADIATION-THERAPY; CHEMORADIOTHERAPY; CONSOLIDATION; DURVALUMAB;
D O I
10.1111/1759-7714.15046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Intensity-modulated radiotherapy (IMRT) has been increasingly used for patients with locally advanced non-small cell lung cancer (LA-NSCLC). However, there are some barriers to implementing IMRT for LA-NSCLC, including the complexity of treatment plan optimization. This study aimed to evaluate the learning curve of lung dose optimization in IMRT for LA-NSCLC and identify the factors that affect the degree of achievement of lung dose optimization.Methods: We retrospectively evaluated 40 consecutive patients with LA-NSCLC who received concurrent chemoradiotherapy at our institution. These 40 patients were divided into two groups: 20 initially treated patients (earlier group) and 20 subsequently treated patients (later group). Patient and tumor characteristics were compared between the two groups. The dose-volume parameter ratio between the actually delivered IMRT plan and the simulated three-dimensional conformal radiotherapy plan was also compared between the two groups to determine the learning curve of lung dose optimization.Results: The dose-volume parameter ratio for lung volume to receive more than 5 Gy (lung V5) and mean lung dose (MLD) significantly decreased in later groups. The spread of the beam path and insufficient optimization of dose coverage of planning target volume (PTV) might cause poor control of lung V5, MLD.Conclusions: A learning curve for lung dose optimization was observed with the accumulation of experience. Appropriate techniques, such as restricting the beam path and ensuring dose coverage of PTV during the optimization process, are essential to control lung dose in IMRT for LA-NSCLC.
引用
收藏
页码:2642 / 2647
页数:6
相关论文
共 16 条
[1]   Simple method for evaluating achievement degree of lung dose optimization in individual patients with locally advanced non-small cell lung cancer treated with intensity modulated radiotherapy [J].
Abe, Takanori ;
Iino, Misaki ;
Saito, Satoshi ;
Aoshika, Tomomi ;
Ryuno, Yasuhiro ;
Ohta, Tomohiro ;
Igari, Mitsunobu ;
Hirai, Ryuta ;
Kumazaki, Yu ;
Miura, Yu ;
Kaira, Kyoichi ;
Kagamu, Hiroshi ;
Noda, Shinei ;
Kato, Shingo .
THORACIC CANCER, 2022, 13 (20) :2890-2896
[2]   Feasibility of intensity modulated radiotherapy with involved field radiotherapy for Japanese patients with locally advanced non-small cell lung cancer [J].
Abe, Takanori ;
Iino, Misaki ;
Saito, Satoshi ;
Aoshika, Tomomi ;
Ryuno, Yasuhiro ;
Ohta, Tomohiro ;
Igari, Mitsunobu ;
Hirai, Ryuta ;
Kumazaki, Yu ;
Miura, Yu ;
Kaira, Kyoichi ;
Kagamu, Hiroshi ;
Noda, Shin-ei ;
Kato, Shingo .
JOURNAL OF RADIATION RESEARCH, 2021, 62 (05) :894-900
[3]   Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC [J].
Antonia, S. J. ;
Villegas, A. ;
Daniel, D. ;
Vicente, D. ;
Murakami, S. ;
Hui, R. ;
Kurata, T. ;
Chiappori, A. ;
Lee, K. H. ;
de Wit, M. ;
Cho, B. C. ;
Bourhaba, M. ;
Quantin, X. ;
Tokito, T. ;
Mekhail, T. ;
Planchard, D. ;
Kim, Y. -C. ;
Karapetis, C. S. ;
Hiret, S. ;
Ostoros, G. ;
Kubota, K. ;
Gray, J. E. ;
Paz-Ares, L. ;
Carpeno, J. de Castro ;
Faivre-Finn, C. ;
Reck, M. ;
Vansteenkiste, J. ;
Spigel, D. R. ;
Wadsworth, C. ;
Melillo, G. ;
Taboada, M. ;
Dennis, P. A. ;
Ozguroglu, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2342-2350
[4]  
Boyle J, 2017, ADV RADIAT ONCOL, V2, P6, DOI 10.1016/j.adro.2016.12.006
[5]   Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial [J].
Chun, Stephen G. ;
Hu, Chen ;
Choy, Hak ;
Komaki, Ritsuko U. ;
Timmerman, Robert D. ;
Schild, Steven E. ;
Bogart, Jeffrey A. ;
Dobelbower, Michael C. ;
Bosch, Walter ;
Galvin, James M. ;
Kavadi, Vivek S. ;
Narayan, Samir ;
Iyengar, Puneeth ;
Robinson, Clifford G. ;
Wynn, Raymond B. ;
Raben, Adam ;
Augspurger, Mark E. ;
MacRae, RobertM. ;
Paulus, Rebecca ;
Bradley, Jeffrey D. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (01) :56-+
[6]   Non-Small Cell Lung Cancer, Version 3.2022 [J].
Ettinger, David S. ;
Wood, Douglas E. ;
Aisner, Dara L. ;
Akerley, Wallace ;
Bauman, Jessica R. ;
Bharat, Ankit ;
Bruno, Debora S. ;
Chang, Joe Y. ;
Chirieac, Lucian R. ;
D'Amico, Thomas A. ;
DeCamp, Malcolm ;
Dilling, Thomas J. ;
Dowell, Jonathan ;
Gettinger, Scott ;
Grotz, Travis E. ;
Gubens, Matthew A. ;
Hegde, Aparna ;
Lackner, Rudy P. ;
Lanuti, Michael ;
Lin, Jules ;
Loo, Billy W. ;
Lovly, Christine M. ;
Maldonado, Fabien ;
Massarelli, Erminia ;
Morgensztern, Daniel ;
Ng, Thomas ;
Otterson, Gregory A. ;
Pacheco, Jose M. ;
Patel, Sandip P. ;
Riely, Gregory J. ;
Riess, Jonathan ;
Schild, Steven E. ;
Shapiro, Theresa A. ;
Singh, Aditi P. ;
Stevenson, James ;
Tam, Alda ;
Tanvetyanon, Tawee ;
Yanagawa, Jane ;
Yang, Stephen C. ;
Yau, Edwin ;
Gregory, Kristina ;
Hughes, Miranda .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (05) :497-530
[7]  
Fleckenstein J, 2016, STRAHLENTHER ONKOL, V192, P75, DOI 10.1007/s00066-015-0900-9
[8]   Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer [J].
Jung, Hyun Ae ;
Noh, Jae Myoung ;
Sun, Jong-Mu ;
Lee, Se-Hoon ;
Ahn, Jin Seok ;
Ahn, Myung-Ju ;
Pyo, Hongryull ;
Ahn, Yong Chan ;
Park, Keunchil .
LUNG CANCER, 2020, 146 :23-29
[9]   Radiotherapy Patterns of Care for Locally-advanced Non-small Cell Lung Cancer in the Pre- and Post-durvalumab Era: A Region-wide Survey in a Japanese Prefecture [J].
Kubo, Nobuteru ;
Kobayashi, Daijiro ;
Iwanaga, Mototaro ;
Matsuura, Masana ;
Higuchi, Keiko ;
Eishima, Jun ;
Muramatsu, Hiroyuki ;
Okano, Naoko ;
Shioya, Mariko ;
Onishi, Masahiro ;
Aoki, Tetsuya ;
Oike, Takahiro ;
Ohno, Tatsuya .
JOURNAL OF RADIATION RESEARCH, 2022, 63 (02) :264-271
[10]   Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer [J].
Mayahara, Hiroshi ;
Uehara, Kazuyuki ;
Harada, Aya ;
Kitatani, Keiji ;
Yabuuchi, Tomonori ;
Miyazaki, Shuichirou ;
Ishihara, Takeaki ;
Kawaguchi, Hiroki ;
Kubota, Hikaru ;
Okada, Hideaki ;
Ninomaru, Taira ;
Shindo, Chihiro ;
Hata, Akito .
RADIATION ONCOLOGY, 2022, 17 (01)